DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Septic Shock - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Septic Shock (86)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone where reactions include septic shock. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 86   Next >>

Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-27

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-24

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1

Doxorubicin Hydrochloride
    Dosage: on day 1,for standard cycles

Doxorubicin Hydrochloride
    Dosage: for escalated cycles on day 1
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3

Etoposide
    Dosage: for the standard cycles, day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-08-23

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s

Cyclophosphamide

Cyclophosphamide

Doxorubicin Hydrochloride

Doxorubicin Hydrochloride

Etoposide

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-08-20

Patient: female, weighing 47.7 kg (104.9 pounds)

Reactions: Cardio-Respiratory Arrest, Metabolic Acidosis, Hepatic Function Abnormal, Arthralgia, Disseminated Intravascular Coagulation, Platelet Count Decreased, Pyrexia, Device Related Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Remicade
    Indication: Rheumatoid Arthritis
    Start date: 2011-12-06

Remicade
    Start date: 2010-09-03

Remicade
    Dosage: 20th dose
    Start date: 2012-06-01

Remicade
    Start date: 2009-08-21

Other drugs received by patient: Folic Acid; Edirol; Lansoprazole; Cefazolin Sodium; Warfarin Sodium



Possible Prednisolone side effects in 9 month old male

Reported by a physician from Portugal on 2012-08-16

Patient: 9 month old male

Reactions: Off Label Use, Multi-Organ Failure, Device Related Infection, Escherichia Infection, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 1 mg/kg, unknown/d
    Indication: Acrodermatitis Enteropathica

Tacrolimus
    Dosage: 0.06 mg/kg, unknown/d
    Indication: Acrodermatitis Enteropathica

Other drugs received by patient: Amlodipine; Captopril



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-08-03

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Infection, Bone Marrow Failure, Septic Shock, Lung Infiltration

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, intravenous
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: see image
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: see image
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 200 mg/m^2 intravenous
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m^2, oral
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, oral
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine Sulfate
    Dosage: 1.4 mg/m^2, intravenous
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-08-02

Patient:

Reactions: Pneumonia, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 18 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Melphalan Hydrochloride
    Dosage: 11 mg/m2, unk
    Start date: 2012-03-22
    End date: 2012-03-25

Prednisolone
    Dosage: 58 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Prednisolone side effects in 9 month old male

Reported by a physician from Portugal on 2012-07-31

Patient: 9 month old male

Reactions: Multi-Organ Failure, Escherichia Infection, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Methylprednisolone
    Dosage: 2 mg/kg/day at initiation
    Indication: Gastrointestinal Disorder

Methylprednisolone
    Dosage: 1.5 mg/kg/day at cessation

Prednisolone
    Dosage: 1 mg/kg/day
    Indication: Gastrointestinal Disorder

Tacrolimus
    Dosage: 0.06 mg/kg/day
    Indication: Gastrointestinal Disorder



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-07-31

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Lung Infiltration, Septic Shock

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650mg/m2
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Dosage: 25 mg/m2, unk
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, unk
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, unk
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, unk
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in 9 month old male

Reported by a health professional (non-physician/pharmacist) from Portugal on 2012-07-27

Patient: 9 month old male

Reactions: Multi-Organ Failure, Septic Shock, Escherichia Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 1 mg/kg, unk
    Indication: Gastrointestinal Disorder

Tacrolimus
    Dosage: 0.06 mg/kg, unk
    Indication: Gastrointestinal Disorder



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a lawyer from Denmark on 2012-07-09

Patient: male

Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Mabthera
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Oncovin
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14

Prednisolone
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-07-14



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-07-05

Patient: male

Reactions: Pneumonia, Respiratory Failure, Septic Shock, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2011-07-14

Mabthera
    Start date: 2011-07-14

Oncovin
    Start date: 2011-07-14

Prednisolone
    Start date: 2011-07-14



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-06-26

Patient: female, weighing 55.0 kg (121.0 pounds)

Reactions: Pneumonia, Septic Shock, Metastases To Lung

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2011-12-15
    End date: 2012-02-18

Afinitor
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-04

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2011-09-01
    End date: 2011-09-13

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2011-10-05
    End date: 2011-11-01

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2012-03-01

Afinitor
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2011-11-02
    End date: 2011-11-30

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    Start date: 2012-01-25

Prednisolone
    Dosage: 15 mg, daily
    Administration route: Oral
    Start date: 2012-01-11
    End date: 2012-01-24

Prednisolone
    Dosage: 20 mg, daily
    Administration route: Oral
    Start date: 2011-12-15
    End date: 2012-01-10

Other drugs received by patient: Mucodyne; Famotidine; Sunitinib Malate; Medicon (Dextromethorphan Hydrobromide); Pydoxal; Vitamin B12; Mucosta; Hirudoid; Nerisona; Locoid; Tramadol Hydrochloride; Loxonin



Possible Prednisolone side effects in male

Reported by a physician from Taiwan, Province of China on 2012-06-19

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: Urosepsis, Pyrexia, Septic Shock, Feeling Cold

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Abiraterone Acetate
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-03-23

Abiraterone Acetate
    Administration route: Oral

Prednisolone
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2012-03-23

Other drugs received by patient: Leuprolide Acetate



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-06-15

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Agranulocytosis, Septic Shock, Blood Pressure Decreased, Abdominal Pain Upper

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atelec
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Candesartan Cilexetil
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Cotrim
    Administration route: Oral
    Indication: Fungal Infection
    Start date: 2012-03-08
    End date: 2012-04-18

Feburic
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2012-01-26
    End date: 2012-04-18

Lansoprazole
    Administration route: Oral
    Indication: Peptic Ulcer
    Start date: 2012-03-08
    End date: 2012-04-18

Livalo
    Administration route: Oral
    Indication: Dyslipidaemia
    End date: 2012-04-18

Onealfa
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2012-03-08
    End date: 2012-04-18

Prednisolone
    Administration route: Oral
    Indication: IGA Nephropathy
    Start date: 2012-03-08
    End date: 2012-04-18



Possible Prednisolone side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-15

Patient: 42 year old male

Reactions: Agranulocytosis, IGA Nephropathy, Blood Pressure Decreased, Septic Shock, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Atelec (Cilnidipine)
    Dosage: 10 mg (5 mg,2 in 1 d) per oral
    Administration route: Oral
    End date: 2012-04-18

Candesartan Cilexetil
    Dosage: 4 mg (4 mg,1 in 1 d) per oral
    Administration route: Oral
    End date: 2012-04-18

Feburic ((febuxostat)
    Dosage: 10 mg (10 mg,1 in 1 d) per oral
    Administration route: Oral
    Start date: 2012-01-26
    End date: 2012-04-18

Lansoprazole
    Dosage: 30 mg (30 mg,1 in 1 d) per oral
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-04-18

Livalo
    Dosage: 2 mg (2 mg,1 in 1 d) per oral
    Administration route: Oral
    End date: 2012-04-18

Onelfa (Alfacalcidol)
    Dosage: 0.5 mcg (0.5 mcg,1 in 1 d) per oral
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-04-18

Prednisolone
    Dosage: 20 mg (20 mg,1 in 1 d) per oral ; 17.5 (17.5 mg,1 in 1 d) per oral ; 15 mg (15 mg,1 in 1 d) per oral
    Administration route: Oral

Prednisolone
    Dosage: 20 mg (20 mg,1 in 1 d) per oral ; 17.5 (17.5 mg,1 in 1 d) per oral ; 15 mg (15 mg,1 in 1 d) per oral
    Administration route: Oral
    End date: 2012-04-18

Prednisolone Sodium Succinate INJ
    Dosage: 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection
    Start date: 2012-03-08

Prednisolone Sodium Succinate INJ
    Dosage: 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection

Prednisolone Sodium Succinate INJ
    Dosage: 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection ; 500 mg (500 mg,1 d) injection

Sulfamethoxazole and Trimethoprim
    Dosage: 2 tab. (1 tab.,2 in 1 d) per oral
    Administration route: Oral
    Start date: 2012-03-08
    End date: 2012-04-18



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-14

Patient: 49 year old male

Reactions: Off Label Use, Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate

Cyclophosphamide

Doxorubicin HCL

Etoposide

Prednisolone
    Administration route: Oral

Procarbazine Hydrochloride
    Administration route: Oral

Vincristine



Possible Prednisolone side effects in 42 year old male

Reported by a physician from Japan on 2012-06-12

Patient: 42 year old male, weighing 61.0 kg (134.2 pounds)

Reactions: Agranulocytosis, Septic Shock, Blood Pressure Decreased, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Atelec
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Candesartan Cilexetil
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Cotrim
    Dosage: 1 df two times a day
    Administration route: Oral
    Indication: Infection Prophylaxis
    Start date: 2012-03-08
    End date: 2012-04-18

Feburic
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2012-01-26
    End date: 2012-04-18

Lansoprazole
    Administration route: Oral
    Indication: Prophylaxis Against Gastrointestinal Ulcer
    Start date: 2012-03-08
    End date: 2012-04-18

Livalo
    Administration route: Oral
    Indication: Dyslipidaemia
    End date: 2012-04-18

Onealfa
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2012-03-08
    End date: 2012-04-18

Prednisolone

Prednisolone
    Administration route: Oral
    Indication: IGA Nephropathy

Prednisolone
    Indication: IGA Nephropathy
    Start date: 2012-03-08

Prednisolone
    Administration route: Oral

Prednisolone
    Administration route: Oral
    End date: 2012-04-18



Possible Prednisolone side effects in 49 year old male

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-06-11

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on d8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650mg/m2 standard cycles 1250 for the escalated cycles
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 35mg/m2,on d1 for escalated cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100mg/m2 for the standard cycles d1 to 3; 200mg/m2 for the escalated cycles from d1-3 iv
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on days 1 to 14 in every 21 day cycle treatment for 6 cycles
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day1-7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on d8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-08

Patient: male

Reactions: Agitation, Confusional State, Skin Exfoliation, Pain in Extremity, General Physical Health Deterioration, Toxic Epidermal Necrolysis, Pyrexia, Multi-Organ Failure, Skin Lesion, Conjunctival Hyperaemia, Acute Respiratory Distress Syndrome, Septic Shock, Oral Mucosa Erosion

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Acetaminophen W / Codeine
    Indication: Back Pain
    Start date: 2012-02-07
    End date: 2012-02-14

Acetylcysteine
    Indication: Bronchial Disorder
    Start date: 2012-03-07
    End date: 2012-03-13

Augmentin
    Indication: Bronchial Disorder
    Start date: 2012-03-07
    End date: 2012-03-14

Bronchokod
    Indication: Bronchial Disorder
    Start date: 2012-03-07
    End date: 2012-03-13

Nexium
    Indication: Back Pain
    Start date: 2012-02-07
    End date: 2012-02-13

Prednisolone
    Indication: Pain
    Start date: 2012-02-01
    End date: 2012-03-13

Temazepam
    Indication: Pain
    Start date: 2012-02-01
    End date: 2012-03-13

Voltaren
    Indication: Back Pain
    Start date: 2012-02-07
    End date: 2012-02-14



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-08

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (4 standard cycles)

Bleomycin Sulfate
    Dosage: 10000 iu, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: 650 mg/m2, day 1 (4 standard cycles)

Doxorubicin HCL
    Dosage: 35 mg/m2, day 1 (2 escalated cycles)
    Indication: Hodgkin's Disease

Doxorubicin HCL
    Dosage: 25 mg/m2, day 1 (4 standard cycles)

Etoposide
    Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
    Indication: Hodgkin's Disease

Etoposide
    Dosage: 100 mg/m2, day 1-3 (4 standard cycles)

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
    Administration route: Oral

Procarbazine Hydrochloride
    Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
    Indication: Hodgkin's Disease

Vincristine
    Dosage: 1.4 mg/m2, day 8 (4 standard cycles)



Possible Prednisolone side effects in 42 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-06-08

Patient: 42 year old male

Reactions: Agranulocytosis, Continuous Haemodiafiltration, Lymphocyte Stimulation Test Positive, Septic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atelec(cilnidipine)
    Dosage: 10 mg oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Candesartan Cilexetil
    Dosage: 4 mg per oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Feburic (Febuxostat)
    Dosage: 10 mg (10 mg, 1-2) 30 mg : 10 mg (10mg, 1 in 1 d) per oral
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2012-01-26
    End date: 2012-04-18

Lansoprazole
    Dosage: per oral
    Administration route: Oral
    Indication: Peptic Ulcer
    Start date: 2012-03-08
    End date: 2012-04-18

Livalo
    Dosage: 2 mg per oral
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Onealfa (Alfacalcidol)
    Dosage: 0.5 mcg per oral
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2012-03-08
    End date: 2012-04-18

Prednisolone
    Dosage: 17.5 mg per oral
    Administration route: Oral
    Indication: IGA Nephropathy
    Start date: 2012-03-08
    End date: 2012-04-18

Sulfamethoxazole and Trimethoprim
    Dosage: 4 df per oral
    Administration route: Oral
    Indication: Fungal Infection
    Start date: 2012-03-08
    End date: 2012-04-18



Possible Prednisolone side effects in 49 year old male

Reported by a physician from Norway on 2012-06-05

Patient: 49 year old male

Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: on day 8
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for standard cycles on day 1
    Indication: Hodgkin's Disease

Cyclophosphamide
    Dosage: for escalated cycles on day 1

Doxorubicin HCL
    Dosage: for escalated cycles on day 1

Doxorubicin HCL
    Dosage: for standard cycles
    Indication: Hodgkin's Disease

Etoposide
    Dosage: for the standard cycles, day 1 to 3

Etoposide
    Dosage: for the escalated cycles on day 1 to 3
    Indication: Hodgkin's Disease

Prednisolone
    Dosage: on day 1 to 14
    Administration route: Oral
    Indication: Hodgkin's Disease

Procarbazine Hydrochloride
    Dosage: day 1 to 7
    Administration route: Oral
    Indication: Hodgkin's Disease

Vincristine
    Dosage: on day 8
    Indication: Hodgkin's Disease



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-06-04

Patient: male, weighing 61.0 kg (134.2 pounds)

Reactions: Agranulocytosis, Septic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Atelec
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Candesartan Cilexetil
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-18

Cotrim
    Administration route: Oral
    Indication: Fungal Infection
    Start date: 2012-03-08
    End date: 2012-04-18

Feburic
    Administration route: Oral
    Indication: Hyperuricaemia
    Start date: 2012-01-26
    End date: 2012-04-18

Lansoprazole
    Administration route: Oral
    Indication: Peptic Ulcer
    Start date: 2012-03-08
    End date: 2012-04-18

Livalo
    Administration route: Oral
    Indication: Dyslipidaemia
    End date: 2012-04-18

Onealfa
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2012-03-08
    End date: 2012-04-18

Prednisolone
    Administration route: Oral
    Indication: IGA Nephropathy
    Start date: 2012-03-08



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-06-01

Patient: male, weighing 41.0 kg (90.2 pounds)

Reactions: Hepatic Function Abnormal, Cystitis Haemorrhagic, Pyrexia, Obliterative Bronchiolitis, Gastritis, Capillary Leak Syndrome, Graft Versus Host Disease in Skin, Transient Ischaemic Attack, Engraft Failure, Hypertriglyceridaemia, Stomatitis, Acute Lymphocytic Leukaemia Recurrent, Chronic Graft Versus Host Disease, Diarrhoea, Graft Versus Host Disease in Intestine, Hypertension, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Prednisolone
    Dosage: unk
    Start date: 2010-05-21
    End date: 2010-06-25

Prednisolone
    Dosage: unk
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2010-05-21
    End date: 2010-09-07

Tacrolimus
    Dosage: unk
    Indication: Prophylaxis Against Graft Versus Host Disease
    Start date: 2010-05-17
    End date: 2010-07-15

Tacrolimus
    Dosage: unk
    Indication: Graft Versus Host Disease
    Start date: 2010-04-21
    End date: 2010-05-16

Tacrolimus
    Dosage: unk
    Start date: 2010-11-30

Tacrolimus
    Dosage: unk
    Start date: 2010-11-07
    End date: 2010-11-29

Thymoglobulin
    Dosage: 55 mg, qd
    Indication: Bone Marrow Conditioning Regimen
    Start date: 2010-04-20
    End date: 2010-04-21

Thymoglobulin
    Dosage: 56 mg, qd
    Start date: 2010-11-03
    End date: 2010-11-04

Other drugs received by patient: Glutathione; Micafungin Sodium; Methylprednisolone Sodium Succinate; Meropenem; Vancomycin Hydrochloride; Pentamidine Isethionate; Ursodiol; Irradiated Platelet Concentrate; Irradiated Erythrocyte Concentrate; Unknown Drug; Etoposide; Busulfan; Granisetron Hydrochloride; Granisetron Hydrochloride; Stronger NEO Minophagen C; Micafungin Sodium; Acetazolamide Sodium; Melphalan Hydrochloride; Meropenem; Filgrastim; Pentamidine Isethionate; Pentamidine Isethionate; Carbenin; Irradiated Erythrocyte Concentrate; Human RED Blood Cells; Sodium Alginate; Cytarabine; Cytarabine; Famotidine; Famotidine; Imipem; Imipem; Hydrocortisone Sodium Succinate; Minocycline Hydrochloride; Meropenem; Acyclovir; Methotrexate; Methotrexate; Methotrexate; Pentamidine Isethionate; Ethyl Icosapentate; Irradiated Erythrocyte Concentrate; Platelets; Human RED Blood Cells; Glycyron; Famotidine; Teicoplanin; Granisetron Hydrochloride; Sodium Bicarbonate; Acetazolamide Sodium; Filgrastim; Voriconazole; Pentamidine Isethionate; Polymyxin B Sulfate; Irradiated Platelet Concentrate; Irradiated Platelet Concentrate; Irradiated Erythrocyte Concentrate; Amino Acids NOS W; Cefozopran Hydrochloride; Spironolactone; Loperamide HCL; Stronger NEO Minophagen C; Stronger NEO Minophagen C; Glutathione; Dalteparin Sodium; Furosemide; Furosemide; Prednisolone Sodium Succinate; Methotrexate; Voriconazole; Voriconazole; Vancomycin Hydrochloride; Ethyl Icosapentate; Irradiated Platelet Concentrate; Irradiated Erythrocyte Concentrate; Irradiated Erythrocyte Concentrate; Hydroxyzine Hydrochloride; Ciprofloxacin; Polaprezinc; Fludara; Famotidine; Glutathione; Dalteparin Sodium; Furosemide; Acyclovir; Methotrexate; Methotrexate; Ursodiol; Phenytoin; Irradiated Erythrocyte Concentrate; Irradiated Erythrocyte Concentrate; Etoposide; Teicoplanin; Hydrocortisone Sodium Succinate; Stronger NEO Minophagen C; Glutathione; Sodium Bicarbonate; Melphalan Hydrochloride; Prednisolone Sodium Succinate; Carbenin; Polymyxin B Sulfate; Levofloxacin; Irradiated Platelet Concentrate; Irradiated Platelet Concentrate; Irradiated Platelet Concentrate; Irradiated Erythrocyte Concentrate; Irradiated Erythrocyte Concentrate; Antithrombin III Human; Antithrombin III Human; Dexamethasone; Granisetron Hydrochloride; Methylprednisolone Sodium Succinate; Prednisolone Sodium Succinate; Voriconazole; Vancomycin Hydrochloride; Irradiated Platelet Concentrate; Irradiated Platelet Concentrate; Irradiated Erythrocyte Concentrate; Anti-Thymocyte Globulin Equine NOS; Rebamipide; Acyclovir; Aspartate Potassium; Platelets; Human RED Blood Cells; Human RED Blood Cells; Human RED Blood Cells; Parenteral



Possible Prednisolone side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-31

Patient: 49 year old female

Reactions: Multi-Organ Failure, Acute Lymphocytic Leukaemia, Pneumonia, Dizziness, Pancytopenia, Septic Shock, Asthenia, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer Stage II

Epirubicin
    Indication: Breast Cancer Stage II

Fluorouracil
    Indication: Breast Cancer Stage II

Prednisolone

Other drugs received by patient: Cytarabine; Vincristine; Doxorubicin HCL; Dexamethasone; Methotrexate



Possible Prednisolone side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30

Patient: 49 year old female

Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 100 mg
    Administration route: Oral
    Indication: Anaemia

Cyclophosphamide
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Leukocytosis
    Start date: 2009-07-01

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Prednisolone
    Indication: Leukocytosis

Prednisolone
    Dosage: 15 mg
    Indication: Anaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017